报价延迟最少15分钟:2026/03/22 15:27 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.95 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.74/0.55
|
|
企业价值
125.58M
|
| 资产负债 |
|
每股账面净值
-0.54
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
71.61M
|
|
每股收益
1.33
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China,Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US. |
